CIMETIDINE
- Product NDC
- 59651-825
- 11-digit product format
- 596510825
- Labeler code
- 59651
- Product ID
- 59651-825_ebd53065-c080-4045-a398-64d3f3b1460f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CIMETIDINE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA218997
- Marketing category
- ANDA
- Marketing start
- 2024-11-12
- Substance
- CIMETIDINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 80061L1WGD | CIMETIDINE | 51481-61-9 | CIMETIDINE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-825-01 | 59651082501 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-825-01) | 2024-11-12 | No | No | Historical |
| 59651-825-05 | 59651082505 | 500 TABLET, FILM COATED in 1 BOTTLE (59651-825-05) | 2024-11-12 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Cimetidine Tablets, USP Rx only | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2024-11-14 | Human Prescription Drug Label | 1 |